Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics
- 12 March 2020
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 224, 113-128
- https://doi.org/10.1016/j.ahj.2020.03.007
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Alterations in cardiac DNA methylation in human dilated cardiomyopathyEMBO Molecular Medicine, 2013
- HDAC4 controls histone methylation in response to elevated cardiac loadJCI Insight, 2013
- Statins Do Not Significantly Affect Muscle Sympathetic Nerve Activity in Humans With Nonischemic Heart Failure: A Double-Blind Placebo-Controlled TrialJournal of Cardiac Failure, 2011
- Distinct Epigenomic Features in End-Stage Failing Human HeartsCirculation, 2011
- Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African AncestryCirculation: Cardiovascular Genetics, 2010
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Transcriptomic Biomarkers for Individual Risk Assessment in New-Onset Heart FailureCirculation, 2008
- Potential Autonomic Nervous System Effects of Statins in Heart FailureHeart Failure Clinics, 2008
- Sudden death prevention in heart failure: The case of CIBIS IIIHeart International, 2006
- A polymorphism within a conserved β 1 -adrenergic receptor motif alters cardiac function and β-blocker response in human heart failureProceedings of the National Academy of Sciences of the United States of America, 2006